Close Menu


The company's BAMS technology combines immuno-enrichment of protein targets with MALDI to enable rapid, multiplexed analysis of proteins and proteoforms.

Among firms presenting on the first day, 10x Genomics revealed it is developing a new high-throughput Chromium instrument, and Guardant plans to launch a comprehensive tissue sequencing assay.

Seer will be able to offer its Proteograph Product Suite for sale with several of the two companies' mass spectrometers.

The PCR-based panel is designed to simultaneously detect SARS-CoV-2, influenza A and B, and respiratory syncytial virus, with results in less than two hours.

Called diaPASEF, the method uses the ion trapping function of the timsTOF instrument to enable more efficient sampling of peptide precursor ions.

Revenues in the third quarter fell to $511.4 million from $521.1million in Q3 2019, beating the consensus Wall Street estimate of $483.7 million.

Called the Integrated Proteomics Pipeline, the platform offers search engine capabilities that will enable better use of collision cross section data.

The company said that it plans to use funds from its recent $18 million Series B round to drive instrument sales and develop AI tools for data analysis.

Canopy offers products and services for gene editing, gene expression analysis and regulation, and bioprocessing, as well as a multi-omic immune profiling platform.

The pair are working on reagents and mass spec approaches to improve isolation and analysis of crosslinked peptides for protein interaction and structural studies.


The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.

According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.

The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.

In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.